These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 21075971

  • 1. The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosis.
    Pender MP.
    Neuroscientist; 2011 Aug; 17(4):351-67. PubMed ID: 21075971
    [Abstract] [Full Text] [Related]

  • 2. Preventing and curing multiple sclerosis by controlling Epstein-Barr virus infection.
    Pender MP.
    Autoimmun Rev; 2009 Jun; 8(7):563-8. PubMed ID: 19254880
    [Abstract] [Full Text] [Related]

  • 3. Epstein-Barr Virus-Specific CD8 T Cells Selectively Infiltrate the Brain in Multiple Sclerosis and Interact Locally with Virus-Infected Cells: Clue for a Virus-Driven Immunopathological Mechanism.
    Serafini B, Rosicarelli B, Veroni C, Mazzola GA, Aloisi F.
    J Virol; 2019 Dec 15; 93(24):. PubMed ID: 31578295
    [Abstract] [Full Text] [Related]

  • 4. Epstein-Barr virus in multiple sclerosis.
    Bagert BA.
    Curr Neurol Neurosci Rep; 2009 Sep 15; 9(5):405-10. PubMed ID: 19664371
    [Abstract] [Full Text] [Related]

  • 5. Epstein-barr virus infection and multiple sclerosis: a review.
    Ascherio A, Munger KL.
    J Neuroimmune Pharmacol; 2010 Sep 15; 5(3):271-7. PubMed ID: 20369303
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The CD8 T Cell-Epstein-Barr Virus-B Cell Trialogue: A Central Issue in Multiple Sclerosis Pathogenesis.
    Veroni C, Aloisi F.
    Front Immunol; 2021 Sep 15; 12():665718. PubMed ID: 34305896
    [Abstract] [Full Text] [Related]

  • 8. Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain.
    Willis SN, Stadelmann C, Rodig SJ, Caron T, Gattenloehner S, Mallozzi SS, Roughan JE, Almendinger SE, Blewett MM, Brück W, Hafler DA, O'Connor KC.
    Brain; 2009 Dec 15; 132(Pt 12):3318-28. PubMed ID: 19638446
    [Abstract] [Full Text] [Related]

  • 9. The role of Epstein-Barr virus in the etiology of multiple sclerosis: a current review.
    Ruprecht K.
    Expert Rev Clin Immunol; 2020 Dec 15; 16(12):1143-1157. PubMed ID: 33152255
    [Abstract] [Full Text] [Related]

  • 10. Epstein-Barr virus and multiple sclerosis. From evidence to therapeutic strategies.
    Fernández-Menéndez S, Fernández-Morán M, Fernández-Vega I, Pérez-Álvarez A, Villafani-Echazú J.
    J Neurol Sci; 2016 Feb 15; 361():213-9. PubMed ID: 26810546
    [Abstract] [Full Text] [Related]

  • 11. Strains of Epstein-Barr virus infecting multiple sclerosis patients.
    Brennan RM, Burrows JM, Bell MJ, Bromham L, Csurhes PA, Lenarczyk A, Sverndal J, Klintenstedt J, Pender MP, Burrows SR.
    Mult Scler; 2010 Jun 15; 16(6):643-51. PubMed ID: 20350958
    [Abstract] [Full Text] [Related]

  • 12. CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis.
    Pender MP.
    Autoimmune Dis; 2012 Jun 15; 2012():189096. PubMed ID: 22312480
    [Abstract] [Full Text] [Related]

  • 13. The Interaction between Viral and Environmental Risk Factors in the Pathogenesis of Multiple Sclerosis.
    Tarlinton RE, Khaibullin T, Granatov E, Martynova E, Rizvanov A, Khaiboullina S.
    Int J Mol Sci; 2019 Jan 14; 20(2):. PubMed ID: 30646507
    [Abstract] [Full Text] [Related]

  • 14. Epstein-Barr virus and multiple sclerosis.
    Pohl D.
    J Neurol Sci; 2009 Nov 15; 286(1-2):62-4. PubMed ID: 19361810
    [Abstract] [Full Text] [Related]

  • 15. Ineffective control of Epstein-Barr-virus-induced autoimmunity increases the risk for multiple sclerosis.
    Vietzen H, Berger SM, Kühner LM, Furlano PL, Bsteh G, Berger T, Rommer P, Puchhammer-Stöckl E.
    Cell; 2023 Dec 21; 186(26):5705-5718.e13. PubMed ID: 38091993
    [Abstract] [Full Text] [Related]

  • 16. Decreased T cell reactivity to Epstein-Barr virus infected lymphoblastoid cell lines in multiple sclerosis.
    Pender MP, Csurhes PA, Lenarczyk A, Pfluger CM, Burrows SR.
    J Neurol Neurosurg Psychiatry; 2009 May 21; 80(5):498-505. PubMed ID: 19015225
    [Abstract] [Full Text] [Related]

  • 17. Epstein-Barr virus genotypes in multiple sclerosis.
    Lindsey JW, Patel S, Zou J.
    Acta Neurol Scand; 2008 Feb 21; 117(2):141-4. PubMed ID: 18184350
    [Abstract] [Full Text] [Related]

  • 18. Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis.
    Sargsyan SA, Shearer AJ, Ritchie AM, Burgoon MP, Anderson S, Hemmer B, Stadelmann C, Gattenlöhner S, Owens GP, Gilden D, Bennett JL.
    Neurology; 2010 Apr 06; 74(14):1127-35. PubMed ID: 20220124
    [Abstract] [Full Text] [Related]

  • 19. Strong EBV-specific CD8+ T-cell response in patients with early multiple sclerosis.
    Jilek S, Schluep M, Meylan P, Vingerhoets F, Guignard L, Monney A, Kleeberg J, Le Goff G, Pantaleo G, Du Pasquier RA.
    Brain; 2008 Jul 06; 131(Pt 7):1712-21. PubMed ID: 18550621
    [Abstract] [Full Text] [Related]

  • 20. Antibody producing B lineage cells invade the central nervous system predominantly at the time of and triggered by acute Epstein-Barr virus infection: A hypothesis on the origin of intrathecal immunoglobulin synthesis in multiple sclerosis.
    Otto C, Hofmann J, Ruprecht K.
    Med Hypotheses; 2016 Jun 06; 91():109-113. PubMed ID: 27142157
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.